InvestorsHub Logo
Followers 1
Posts 180
Boards Moderated 0
Alias Born 02/09/2017

Re: None

Wednesday, 07/19/2017 11:05:49 AM

Wednesday, July 19, 2017 11:05:49 AM

Post# of 1087
Vertex Pharmaceuticals just blew Corbus's cystic fibrosis application out of the water. Vertex is showing an almost 10% increase in lung function. Corbus, correct me if I'm wrong, nada.

VRTX mkt cap 41B
CRBP mkt cap 324M, that's an M

Unless Corbus can show an improvement in lung function shouldn't even bother wasting money on phase 3. A bigger competitor has a better product. Game over.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRBP News